PRELUDE CAPITAL MANAGEMENT, LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 96 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$96,000
+37.1%
11,600
+12.6%
0.00%0.0%
Q4 2020$70,000
-84.2%
10,300
-74.1%
0.00%
-90.5%
Q3 2020$443,000
+41.1%
39,800
-20.6%
0.02%
+23.5%
Q2 2020$314,000
+554.2%
50,100
+92.7%
0.02%
+466.7%
Q1 2020$48,000
-4.0%
26,000
+168.2%
0.00%
-25.0%
Q1 2018$50,000
+35.1%
9,6950.0%0.00%
+33.3%
Q4 2017$37,0009,6950.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders